Skip to main content
OpenTrials

Clinical trial condition

Secondary Hyperparathyroidism

Explore clinical trials studying Secondary Hyperparathyroidism. Study availability and eligibility vary by location and protocol.

99 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Secondary Hyperparathyroidism trial results

Completed

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

NCT00123461

Conditions
Chronic Disease, Chronic Renal Insufficiency, Disease Attributes, +16 more
Locations
  • AKDHC Medical Research Services Phoenix, Arizona, United States
  • UCLA Diabetes Reseach Center Alhambra, California, United States
  • Apex Research of Riverside Riverside, California, United States
  • George Washington University Hospital Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

NCT01149291

Conditions
Chronic Disease, Disease Attributes, End Stage Renal Disease, +16 more
Locations
  • Site Reference ID/Investigator# 37822 Antalya, Turkey (Türkiye)
  • Site Reference ID/Investigator# 68286 Antalya, Turkey (Türkiye)
  • Site Reference ID/Investigator# 40677 Antalya, Turkey (Türkiye)
  • Site Reference ID/Investigator# 85153 Istanbul, Turkey (Türkiye)
View all 22 locations
View Trial Details
Completed

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

NCT01083849

Conditions
Chronic Disease, Disease Attributes, Endocrine System Diseases, +18 more
Locations
  • Site Reference ID/Investigator# 64522 Feldkirch, Austria
  • Site Reference ID/Investigator# 53506 Graz, Austria
  • Site Reference ID/Investigator# 53524 Graz, Austria
  • Site Reference ID/Investigator# 74733 Innsbruck, Austria
View all 87 locations
View Trial Details
Completed

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

NCT00742716

Conditions
Chronic Disease, Chronic Kidney Disease, Chronic Renal Failure, +18 more
Locations
  • Pines Clinical Research, Inc. Pembroke Pines, Florida, United States
  • Boise Kidney and Hypertension Institute Meridian, Idaho, United States
  • Western New England Renal & Transplant Associates (WNERTA) Springfield, Massachusetts, United States
  • Southeast Renal Research Institute Chattanooga, Tennessee, United States
View Trial Details
Completed

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

NCT00888069

Conditions
Chronic Disease, Chronic Kidney Disease, Chronic Renal Failure, +18 more
Locations
  • Pivotal Research Centers Peoria, Arizona, United States
  • Research by Design Evergreen Park, Illinois, United States
  • Western New England Renal & Transplant Associates Springfield, Massachusetts, United States
  • Twin Cities Clinical Research Brooklyn Center, Minnesota, United States
View Trial Details

Related conditions